Price T Rowe Associates Inc Ardelyx, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,074,488 shares of ARDX stock, worth $5.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,074,488
Previous 1,719,071
37.5%
Holding current value
$5.53 Million
Previous $12.7 Million
41.87%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ARDX
# of Institutions
219Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$111 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$90.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$70 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$62.5 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$46.1 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $796M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...